Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1)(2) | Proposed Maximum Offering Price Per Share(3) | Maximum Aggregate Offering Price(3) | Fee Rate | Amount of Registration Fee | ||||||||||||||||||||||||||||||||||||||||
Equity | Common Stock, $0.001 par value per share | Rules 457(c) and 457(h)(1) | 3,774,968 | $ | 13.18 | $ | 49,754,078 | $ | 0.0001531 | $ | 7,617 | ||||||||||||||||||||||||||||||||||||
Total Offering Amounts | $ | 7,617 | |||||||||||||||||||||||||||||||||||||||||||||
Total Fee Offsets | $ | — | |||||||||||||||||||||||||||||||||||||||||||||
Net Fee Due | $ | 7,617 | |||||||||||||||||||||||||||||||||||||||||||||
(1) | Consists of (i) 3,540,874 additional shares reserved for issuance under the Avalo Therapeutics, Inc. Fourth Amended and Restated 2016 Equity Incentive Plan (the “2016 Stock Plan”) and (ii) 234,094 additional shares reserved for issuance under the Avalo Therapeutics, Inc. 2016 Employee Stock Purchase Plan (the “ESPP”). An aggregate of 8,286 shares issuable under the 2016 Plan and an aggregate of 1,134 shares issuable under the ESPP (both amounts adjusted to give effect to previously effected reverse stock splits) had been previously registered pursuant to Registration Statement No. 333-211490, Registration Statement No. 333-211491, Registration Statement No. 333-226767, Registration Statement No. 333-241661, Registration Statement No. 333-256082, Registration Statement No. 333-256083, Registration Statement No. 333-268199 and Registration Statement No. 333-271655. | ||||||||||||||||||||||||||||||||||||||||||||||
(2) | Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement also covers any additional shares of Registrant’s common stock that become issuable under the 2016 Stock Plan by reason of any stock dividend, stock split, recapitalization, or other similar transaction that results in an increase in the number of outstanding shares of the Registrant’s common stock. | ||||||||||||||||||||||||||||||||||||||||||||||
(3) | Estimated in accordance with Rules 457(c) and 457(h)(1) of the Securities Act solely for the purpose of calculating the registration fee based upon the average of the high and low prices of the Registrant’s common stock on the NASDAQ Capital Market on November 5, 2024. |